Girl Finds Cancer While Fake Tanning
"Lymphoma is the most common cancer among people under 30 yet, for many, the first time they hear about it is when they are diagnosed. Clare Hutchinson spoke to student Kathryn Fish, who is currently undergoing treatment for Hodgkin’s lymphoma
KATHRYN FISH is like any other student – she likes to wear nice clothes, party with her friends and get the most out of life.
The only difference is that three months ago, she was diagnosed with Hodgkin’s lymphoma.
The 20-year-old from Danescourt, Cardiff, was getting ready for a night out with her housemates in Bristol when she noticed a lump on her neck.
“I remember it was a Thursday night and we were all planning to go out on Friday so we were doing our usual girly routine of fake tanning,” she said.
“It was 11.30pm and I was fake tanning my neck when I found a lump a little smaller than a golf ball just above my collar bone."
Read More: http://www.walesonline.co.uk/news/health-news/2010/11/01/student-discove...
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
